New diagnostic technology may lead to individualized treatments for prostate cancer




A research team has enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body. If more studies confirm the technology's effectiveness, the NanoVelcro Chip device could enable doctors to access and identify cancerous cells in the bloodstream, which would provide the diagnostic information needed to create individually tailored treatments for patients w...

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/g...

Lunes, 1 de Abril 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección